The expression of SULT1A1 and SULT4A1 was significantly higher in NASH patients with cirrhosis relative to such patients with steatosis; they were also significantly elevated in NASH patients with cirrhosis relative to healthy controls, patients with steatosis alone, and patients with fatty liver NASH. The gene discussed is SULT4A1; the disease is metabolic dysfunction-associated steatohepatitis.